DE602007008393D1 - Mittel und verfahren zur diagnose und behandlung von krebs auf basis des frmd3-gens - Google Patents

Mittel und verfahren zur diagnose und behandlung von krebs auf basis des frmd3-gens

Info

Publication number
DE602007008393D1
DE602007008393D1 DE602007008393T DE602007008393T DE602007008393D1 DE 602007008393 D1 DE602007008393 D1 DE 602007008393D1 DE 602007008393 T DE602007008393 T DE 602007008393T DE 602007008393 T DE602007008393 T DE 602007008393T DE 602007008393 D1 DE602007008393 D1 DE 602007008393D1
Authority
DE
Germany
Prior art keywords
frmd3
diagnosis
treatment
medium
cancer based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008393T
Other languages
English (en)
Inventor
Peter Angel
Bettina Hartenstein
Doreen Haase
Michael Meister
Thomas Muley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of DE602007008393D1 publication Critical patent/DE602007008393D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602007008393T 2006-04-24 2007-04-23 Mittel und verfahren zur diagnose und behandlung von krebs auf basis des frmd3-gens Active DE602007008393D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112978A EP1849878A1 (de) 2006-04-24 2006-04-24 Mittel und Verfahren zur Diagnose und Behandlung von Krebs, basierend auf dem FRMD3-Gen
PCT/EP2007/053943 WO2007122213A2 (en) 2006-04-24 2007-04-23 Means and methods for diagnosing and treating cancer based on the frmd3 gene

Publications (1)

Publication Number Publication Date
DE602007008393D1 true DE602007008393D1 (de) 2010-09-23

Family

ID=36888977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008393T Active DE602007008393D1 (de) 2006-04-24 2007-04-23 Mittel und verfahren zur diagnose und behandlung von krebs auf basis des frmd3-gens

Country Status (5)

Country Link
US (1) US20100151588A1 (de)
EP (2) EP1849878A1 (de)
AT (1) ATE477340T1 (de)
DE (1) DE602007008393D1 (de)
WO (1) WO2007122213A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9879930B2 (en) * 2016-01-19 2018-01-30 Charles B. Cassels Compact action spring and buffer assembly
US10690425B2 (en) 2017-12-22 2020-06-23 Charles B. Cassels Firearm with locked breech rotating bolt pistol
CN116327892B (zh) * 2022-12-23 2025-10-14 郑州大学 抗结直肠癌的蛋白及其基因片段

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275794A1 (en) * 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
WO2006124022A1 (en) * 2005-05-13 2006-11-23 Vanandel Research Institute Microarray gene expression profiling in subtypes of clear cell renal cell carcinoma
TW200730825A (en) * 2005-10-21 2007-08-16 Genenews Inc Method and apparatus for correlating levels of biomarker products with disease

Also Published As

Publication number Publication date
US20100151588A1 (en) 2010-06-17
WO2007122213A3 (en) 2007-12-21
EP2010673A2 (de) 2009-01-07
EP2010673B1 (de) 2010-08-11
ATE477340T1 (de) 2010-08-15
WO2007122213A2 (en) 2007-11-01
EP1849878A1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
EP2320057A4 (de) Diagnosevorrichtung für kraftstoffsparenden betrieb, diagnosesystem für kraftstoffsparenden betrieb, antriebsaggregatsteuerung, vorrichtung zur auswertung von kraftstoffsparendem betrieb und diagnoseverfahren für kraftstoffsparenden betrieb
ATE526421T1 (de) Verfahren und reagenzien zur behandlung und diagnose von altersbedingter makuladegeneration
EP1904630A4 (de) Verfahren zur behandlung und diagnose von epilepsie durch nachweisen von mutationen im scn1a-gen
ATE488251T1 (de) Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
EP2373815A4 (de) Mikro-rna-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von ovarialkarzinom
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
DE602007011592D1 (de) MITTEL UND VERFAHREN ZUR PROGNOSE ODER DIAGNOSE VON DIABETES typ II
ATE371738T1 (de) Mittel und verfahren zur diagnose und behandlung affektiver störungen
WO2010015607A3 (en) Method of evaluating oral cancer risk in human
EP2024745A4 (de) Tests zur diagnose und beurteilung von behandlungsoptionen für morbus fabry
EP2029743A4 (de) Verfahren zur diagnose und behandlung von schwangerschaftskomplikationen
WO2014059196A3 (en) Diagnosis and treatment of sma and smn deficiency
EP3522899A4 (de) Verbindungen und zusammensetzungen zur behandlung von leishmaniose und verfahren zur diagnose und behandlung damit
EP1869212A4 (de) Verwendung von id4 zur diagnose und behandlung von krebs
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
DE602007008393D1 (de) Mittel und verfahren zur diagnose und behandlung von krebs auf basis des frmd3-gens
DE60219809D1 (de) Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen
EP1689347A4 (de) Verfahren und reagenzien zur behandlund prävention und diagnose von bunyavirus infektion
EP2291544A4 (de) Genetische veränderungen auf chromosomen 21q, 6q und 15q sowie verfahren zur verwendung davon bei der diagnose und behandlung von typ-i-diabetes
DE602004029061D1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
DE60037126D1 (de) POLYMORPHISMEN DES MENSCHLICHEN HPXR Gens UND IHRE ANWENDUNG IN DIAGNOSE UND THERAPIE
EP4453235A4 (de) Zusammensetzungen und verfahren zur diagnose, behandlung und prävention von nierenerkrankungen
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
EP1602930A3 (de) Verwendungen von an GPR49 bindenden Substanzen zur Diagnose und Behandlung von Krebs
DE602007006284D1 (de) Verfahren zur vorhersage des ansprechens von patienten mit multipler sklerose auf eine interferontherapie und zur diagnose von multipler sklerose